Safety and efficacy of rivastigmine and memantine combined for treatment of patients with Alzheimer’s disease: a retrospective study
The combination of the two drugs was more effective in alleviating AD symptoms with comparable safety. It also showed an edge in suppressing pro-inflammatory cytokines and Tau in AD.
Authors
- Haiyan Wang (ORCID: https://orcid.org/0000-0001-8452-1273)
Institutions
- Zoucheng People's Hospital (CN)
Publication Details
- Journal
- American Journal of Translational Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/yopp4162
- Citations
- 1
- Primary Topic
- Cholinesterase and Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.39